ML19332C275

Discusses Implementation of 10CFR26,App a, Fitness for Duty Program Guidelines. Util Plans to Set More Stringent cut-off Levels in Areas Listed & Add Test for 6-monoacetylmorphine in Confirmatory Test for Opiate

ML19332C275
Person / Time
Site:	Davis Besse
Issue date:	11/06/1989
From:	Shelton D TOLEDO EDISON CO.
To:	NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM)
References
1734, NUDOCS 8911270087
Download: ML19332C275 (2)

Text

r-t i'y*-

j.

TOLEDO

%mm EDISON A Centenor (nerDy Comrmy DUNAdl C. SHELTON Voe Prescent-Naker Docket Number 50-346 Nd"3

. License Number NPF-3 Serial Number 1734 November 6, 1989 United States Nuclear Regulatory Commission Document Control Desk.

Vashington, D. C. 20555 .

i Subj ec t: Implementation of 10CFR26, Appendix A, Fitness for Duty Frogram Guidelines Gentlemen Appendix A,.Subpart A-1.1(2) of 10CFR26, Fitness for Duty rule, allows licensees to set more stringent cut-off levels than specified.or test'for-

' substances other than specified in 10CFR26, Appendix A provided that the NRC is informed of such a deviation within 60 days of implementing such a change.

' Toledo' Edison plans to set more stringent cut-off levels in two areas, as follows:

1) 10CFR26, Appendix A, Section 2.4 (g)(14) currently states: "If the temperature of the urine specimen is outside the range of 32.5 degrees C - 37.7 degrees C /90.5 degrees F - 99.8 degrees F...."

Toledo Edison plans to change the temperature range to 34.4 degrees C 1

-37 degrees C /94 degrees F - 98.6 degrees F. j

2) 10CFR26, Appendix A, Section 2.7 (e)(1) states that the. initial test for cut-off level for marijuana metabolites is 100 ng/ml. Toledo l

l Edison plans to add another test for 50 ng/ml.

Additionally, TE identified the following two items.vithin 10CFR26, Appendix A l that deviate from NIDA certification:

1) 10CFR26, Appendix A, Section 2.7 (f)(3) currently states: "The L

analytic procedure for confirmatory analysis of blood specimens -l voluntarily provided by individuals testing positive for alcohol on a breath test shall be gas chromatography analysis."

8911270087 891106 PDR ADOCK 05000346 0 P PDC 0(

THE TOLEDO EDISON COMPANY EDISON PLAZA 300 MADISON AVENUE TOLEDO. OHIO 43652

g-y"

.?-

! . ' ' *1 , ' . ' Dockht-Nu2bir50-346 g JJ Lic nse Number'NPF-3

?

, -Serial Number 1734

.Page 2.

NIDA-certification does not require a gas chromutography analysis for blood alcohol content, however, a test vill be added to allow TE to meet 10CFR26 Appendix A guidelines.

2) '10CFR26, Appendix A, Section 2.7 (f)(5) currently states:

" Confirmatory tests for opiates shall include a test for 6-monoacetylmorphine (MAM) if the screening test is presumptive positive for morphine."

Toledo Edison plans to add a test for 6-monoacetylmorphine in the confirmatory test for opiate.

If you have any questions concerning this matter, please contact Mr. R. V. Schrauder, Nuclear Licensing Manager, at (419) 249-2366, t Very truly yours, f A -----

EBS/ssg s

cc: P. M. Byron, DB-1 NRC Senior Resident Inspector l

.A. B. Davis, Regional Administrator, NRC Region III' T. V. Vambach, DB-1 NRC Senior Project Manager i

I i

l i

}

t l

l

c. a